Childhood retinal dystrophies are highly heterogeneous

Article

A paper in the British Journal of Ophthalmology states that childhood retinal dystrophies are highly heterogeneous.

A paper in the British Journal of Ophthalmology states that childhood retinal dystrophies are highly heterogeneous.

The prospective, population-based, cross-sectional study, compiled by Professor Jugnoo S. Rahi et al., MRC Centre of Epidemiology for Child Health, UCL Institute of Child Health, London, UK, included 241 patients with 24 different diagnoses.

All patients were aged

There was a higher rate of hereditary retinal disorders seen in males, compared to females and in Asian children compared to white children. Additional systemic disorders were found in 14% of children and 13% had dual sensory impairment.

Annual incidence of retinal disorders was 1.4/100,000 children aged between 0 and 15 years, and 22.3/100,000 children by the age of 16 years.

The study provides useful information on disease incidence, distributions and management. The results are significant to the development of future treatments and novel therapies.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.